149 related articles for article (PubMed ID: 9454773)
21. The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells.
Marathi UK; Howell SR; Ashmun RA; Brent TP
Blood; 1996 Sep; 88(6):2298-305. PubMed ID: 8822951
[TBL] [Abstract][Full Text] [Related]
22. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression.
Hoshino T; Wang J; Devetten MP; Iwata N; Kajigaya S; Wise RJ; Liu JM; Youssoufian H
Blood; 1998 Jun; 91(11):4379-86. PubMed ID: 9596688
[TBL] [Abstract][Full Text] [Related]
23. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.
Kupfer GM; D'Andrea AD
Blood; 1996 Aug; 88(3):1019-25. PubMed ID: 8704210
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
[TBL] [Abstract][Full Text] [Related]
25. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2.
Kupfer GM; Yamashita T; Naf D; Suliman A; Asano S; D'Andrea AD
Blood; 1997 Aug; 90(3):1047-54. PubMed ID: 9242535
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of the fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis.
Wang J; Otsuki T; Youssoufian H; Foe JL; Kim S; Devetten M; Yu J; Li Y; Dunn D; Liu JM
Cancer Res; 1998 Aug; 58(16):3538-41. PubMed ID: 9721856
[TBL] [Abstract][Full Text] [Related]
27. Developmental expression of the Fac gene correlates with congenital defects in Fanconi anemia patients.
Krasnoshtein F; Buchwald M
Hum Mol Genet; 1996 Jan; 5(1):85-93. PubMed ID: 8789444
[TBL] [Abstract][Full Text] [Related]
28. The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-alpha and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily.
Koh PS; Hughes GC; Faulkner GR; Keeble WW; Bagby GC
Exp Hematol; 1999 Jan; 27(1):1-8. PubMed ID: 9923438
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
[TBL] [Abstract][Full Text] [Related]
30. Cytoplasmic localization of a functionally active Fanconi anemia group A-green fluorescent protein chimera in human 293 cells.
Kruyt FA; Waisfisz Q; Dijkmans LM; Hermsen MA; Youssoufian H; Arwert F; Joenje H
Blood; 1997 Nov; 90(9):3288-95. PubMed ID: 9345010
[TBL] [Abstract][Full Text] [Related]
31. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.
Taniguchi T; D'Andrea AD
Blood; 2002 Oct; 100(7):2457-62. PubMed ID: 12239156
[TBL] [Abstract][Full Text] [Related]
32. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
33. The Fanconi anemia core complex forms four complexes of different sizes in different subcellular compartments.
Thomashevski A; High AA; Drozd M; Shabanowitz J; Hunt DF; Grant PA; Kupfer GM
J Biol Chem; 2004 Jun; 279(25):26201-9. PubMed ID: 15082718
[TBL] [Abstract][Full Text] [Related]
34. Novel mutations and polymorphisms in the Fanconi anemia group C gene.
Gibson RA; Morgan NV; Goldstein LH; Pearson IC; Kesterton IP; Foot NJ; Jansen S; Havenga C; Pearson T; de Ravel TJ; Cohn RJ; Marques IM; Dokal I; Roberts I; Marsh J; Ball S; Milner RD; Llerena JC; Samochatova E; Mohan SP; Vasudevan P; Birjandi F; Hajianpour A; Murer-Orlando M; Mathew CG
Hum Mutat; 1996; 8(2):140-8. PubMed ID: 8844212
[TBL] [Abstract][Full Text] [Related]
35. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene.
Whitney MA; Royle G; Low MJ; Kelly MA; Axthelm MK; Reifsteck C; Olson S; Braun RE; Heinrich MC; Rathbun RK; Bagby GC; Grompe M
Blood; 1996 Jul; 88(1):49-58. PubMed ID: 8704201
[TBL] [Abstract][Full Text] [Related]
36. Complementation group assignments in Fanconi anemia fibroblast cell lines from North America.
Jakobs PM; Fiddler-Odell E; Reifsteck C; Olson S; Moses RE; Grompe M
Somat Cell Mol Genet; 1997 Jan; 23(1):1-7. PubMed ID: 9217996
[TBL] [Abstract][Full Text] [Related]
37. A functionally active retrovirus vector for gene therapy in Fanconi anemia group C.
Walsh CE; Grompe M; Vanin E; Buchwald M; Young NS; Nienhuis AW; Liu JM
Blood; 1994 Jul; 84(2):453-9. PubMed ID: 7517716
[TBL] [Abstract][Full Text] [Related]
38. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining.
Escarceller M; Buchwald M; Singleton BK; Jeggo PA; Jackson SP; Moustacchi E; Papadopoulo D
J Mol Biol; 1998 Jun; 279(2):375-85. PubMed ID: 9642044
[TBL] [Abstract][Full Text] [Related]
39. Protein replacement by receptor-mediated endocytosis corrects the sensitivity of Fanconi anemia group C cells to mitomycin C.
Youssoufian H; Kruyt FA; Li X
Blood; 1999 Jan; 93(1):363-9. PubMed ID: 9864182
[TBL] [Abstract][Full Text] [Related]
40. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner.
Qiao F; Moss A; Kupfer GM
J Biol Chem; 2001 Jun; 276(26):23391-6. PubMed ID: 11297559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
